Market Overview:
The global intravenous solution compounder market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising demand for home healthcare services, and technological advancements in intravenous (IV) therapy devices. Based on type, the global intravenous solution compounder market is segmented into countertop IV solution compounders and standalone IV solution compounders. The countertop IV solution compounders segment is expected to account for a larger share of the market in 2018 owing to their low cost and easy portability. However, the standalone IV solution compounder segment is projected to grow at a higher CAGR during the forecast period due to its ability to provide greater flexibility with respect to drug compounding and dosing options. Based on application, the global intravenous Solution Compounder Market is divided into hospitals, clinics, and others segments. The hospitals segment accounted for majority of revenue share in 2017 owing high adoption rates across developed countries coupled with rising number of hospital admissions globally due chronic diseases such as cancer and diabetes mellitus . However ,the clinics Segment Is Expected To Grow At A Higher Rate Over The Forecast Period Owing To Rising Prevalence Of Chronic Diseases And Increasing Demand For Home Healthcare Services Globally .
Product Definition:
An intravenous solution compounder is a device used to mix medications and other solutions together before they are given intravenously (through a vein). This type of machine is important because it allows healthcare providers to customize the doses of different medications and solutions that are given to patients.
Countertop Intravenous Solution Compounder:
Countertop Intravenous Solution Compounder is a device used to make intravenous (IV) solutions. It's an all-in-one unit that consists of a countertop component and a mobile part, which can be taken anywhere. The main function of this device includes the addition of solutes to the IV solution, which makes it possible for doctors or nurses to administer medications without having to use injections every time they are needed.
Standalone Intravenous Solution Compounder:
The intravenous solution compounding process is carried out by healthcare professionals to provide a customized intravenous (IV) infusion of medication. The major aim of the process is to deliver the exact amount of drugs at the right time and in the most effective way. Standalone Intravenous Solution Compounders (S-IVSC) are used for this purpose.
Application Insights:
Based on the application, the global intravenous solution compounder market is segmented into hospital, clinic and others. The hospital segment dominated the market in 2017 owing to increasing number of patients suffering from various diseases and rising government initiatives for improving healthcare infrastructure at a global level. For instance, according to WHO, by 2030 there will be more than 90 million additional health care professionals required globally which will increase demand for IV solutions over the forecast period.
The Clinic segment is expected to grow significantly over the forecast period due to growing awareness among people regarding their medical conditions and an increased number of clinics offering IV therapy services. Increasing availability of advanced technology that helps in reducing wastage coupled with a reduced cost compared to hospitals may encourage people living in rural areas as well as remote places where access to conventional healthcare facilities is difficult or expensiveto opt for IVS instead which can be delivered directly into their veins at home without any assistance from medical personnel.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors driving the growth of this regional market. Moreover, increasing demand for cost-effective & faster treatment options is also expected to drive the North American market during the forecast period.
Asia Pacific is anticipated to be one of the fastest growing regions owing to rising patient awareness about intravenous (IV) solutions and their advantages over other modes of administration as well as increasing government initiatives for improving healthcare facilities in developing countries such as India and China.
Europe accounted for more than 25% share in 2017 owing to its well-developed healthcare sector along with an increase in medical tourism activities supported by low prices offered by European manufacturers compared to that offered by U.S.
Growth Factors:
- Increasing demand for intravenous solutions from hospitals and clinics
- Growing number of patients suffering from chronic diseases
- Rising prevalence of cancer and other life-threatening diseases
- Technological advancements in intravenous solution compounding devices and software
- Proliferation of home healthcare services
Scope Of The Report
Report Attributes
Report Details
Report Title
Intravenous Solution Compounder Market Research Report
By Type
Countertop Intravenous Solution Compounder, Standalone Intravenous Solution Compounder
By Application
Hospital, Clinic, Others
By Companies
ARxIUM, Baxter, ICU Medical, B.Braun, Grifols, Pfizer, Omnicell
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
147
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Intravenous Solution Compounder Market Report Segments:
The global Intravenous Solution Compounder market is segmented on the basis of:
Types
Countertop Intravenous Solution Compounder, Standalone Intravenous Solution Compounder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ARxIUM
- Baxter
- ICU Medical
- B.Braun
- Grifols
- Pfizer
- Omnicell
Highlights of The Intravenous Solution Compounder Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Countertop Intravenous Solution Compounder
- Standalone Intravenous Solution Compounder
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intravenous Solution Compounder Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intravenous Solution Compounder is a medication that helps to make intravenous solutions more effective. It can help to prevent infection and reduce the amount of pain felt during intravenous treatments.
Some of the key players operating in the intravenous solution compounder market are ARxIUM, Baxter, ICU Medical, B.Braun, Grifols, Pfizer, Omnicell.
The intravenous solution compounder market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Intravenous Solution Compounder Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Intravenous Solution Compounder Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Intravenous Solution Compounder Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Intravenous Solution Compounder Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Intravenous Solution Compounder Market Size & Forecast, 2020-2028
4.5.1 Intravenous Solution Compounder Market Size and Y-o-Y Growth
4.5.2 Intravenous Solution Compounder Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Countertop Intravenous Solution Compounder
5.2.2 Standalone Intravenous Solution Compounder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Intravenous Solution Compounder Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Intravenous Solution Compounder Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Countertop Intravenous Solution Compounder
9.6.2 Standalone Intravenous Solution Compounder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Countertop Intravenous Solution Compounder
10.6.2 Standalone Intravenous Solution Compounder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Countertop Intravenous Solution Compounder
11.6.2 Standalone Intravenous Solution Compounder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Countertop Intravenous Solution Compounder
12.6.2 Standalone Intravenous Solution Compounder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Countertop Intravenous Solution Compounder
13.6.2 Standalone Intravenous Solution Compounder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Intravenous Solution Compounder Market: Competitive Dashboard
14.2 Global Intravenous Solution Compounder Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ARxIUM
14.3.2 Baxter
14.3.3 ICU Medical
14.3.4 B.Braun
14.3.5 Grifols
14.3.6 Pfizer
14.3.7 Omnicell
